재택 의료 시장 규모, 점유율 및 동향 분석 리포트 : 구성 요소별, 적응증별, 지역별 및 부문별 예측(2026-2033년)

Home Healthcare Market Summary

The global home healthcare market size was estimated at USD 458.3 billion in 2025 and is projected to reach USD 1,015.8 billion by 2033, growing at a CAGR of 10.5% from 2026 to 2033. The market is driven by rising demand for cost-effective alternatives to curb rising healthcare costs and the growing penetration of the virtual and remote care industry.

Increasing treatment costs are one of the major concerns for governments and health organizations. Home healthcare is a cost-efficient alternative to an expensive hospital stay. For instance, in September 2025, Cardinal Health expanded its Velocare at-Home Solutions business to support hospital-at-home programs by enabling logistics, supply chain, and rapid delivery of medical supplies to patients' homes.

The section below outlines the key factors driving the growth of the home healthcare market, highlighting the advancements in technology and the rapid expansion of telehealthservices. In addition, rising awareness of home care facilities and increasing disposable income are further driving the market.

Global Home Healthcare Market Report Segmentation

This report forecasts revenue growth at the global, regional, and country levels and provides an analysis on the latest industry trends and opportunities in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global home healthcare market report on the basis of component, indication, and region:

• Component Outlook (Revenue, USD Million, 2021 - 2033)
• Equipment
  • Therapeutic
  • Home respiratory therapy equipment
  • Insulin delivery devices
  • Home IV pumps
  • Home dialysis equipment
  • Others
  • Diagnostic
  • Diabetic care unit
  • BP monitors
  • Multi para diagnostic monitors
  • Home pregnancy and fertility kits
  • Apnea and sleep monitors
  • Holter monitors
  • Heart rate monitors
  • Others
  • Mobility Assist
  • Wheel chair
  • Home medical furniture
  • Walking assist devices
• Services
  • Skilled Home Healthcare Services
  • Physician primary care
  • Nursing care
  • Physical/occupational/speech therapy
  • Nutritional support & infusion therapy
  • Hospice & palliative care
  • Others
  • Unskilled Home Healthcare Services
• Indication Outlook (Revenue, USD Million, 2021 - 2033)
• Cardiovascular Disorder & Hypertension
• Diabetes & Kidney Disorders
• Neurological & Mental Disorders
• Respiratory Disease & COPD
• Maternal Disorders
• Mobility Disorders
• Cancer
• Wound Care
• Others
• Regional Outlook (Revenue, USD Million, 2021 - 2033)
• North America
  • U.S.
  • Canada
• Europe
  • UK
  • Germany
  • Sweden
  • France
  • Italy
  • Russia
  • Netherlands
  • Spain
  • Ireland
  • Switzerland
  • Denmark
• Asia Pacific
  • China
  • Japan
  • India
  • Australia
  • Singapore
  • Malaysia
  • Thailand
  • Philippines
  • South Korea
  • New Zealand
• Latin America
  • Brazil
  • Argentina
  • Mexico
• Middle East & Africa (MEA)
  • South Africa
  • Saudi Arabia
  • Oman
  • UAE
  • Egypt

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
• 1.2. Market Definitions
  • 1.2.1. Component
  • 1.2.2. Indication
• 1.3. Regional Scope
• 1.4. Estimates and Forecast Timeline
• 1.5. Information Procurement
  • 1.5.1. Purchased Database
  • 1.5.2. GVR's Internal Database
  • 1.5.3. Secondary Sources & Third-Party Perspectives
  • 1.5.4. Primary Research
  • 1.5.5. Details of Primary Research
• 1.6. Information Analysis
  • 1.6.1. Data Analysis Models
• 1.7. Market Formulation & Data Visualization
  • 1.7.1. Commodity Flow Analysis
    • 1.7.1.1. Approach 1: Commodity flow approach
    • 1.7.1.2. Approach 2: Country wise market estimation using bottom-up approach
• 1.8. Data Validation & Publishing
• 1.9. Global Market: CAGR Calculation
• 1.10. List of Secondary Sources
• 1.11. List of Primary Sources

Chapter 2. Executive Summary

• 2.1. Market Snapshot
• 2.2. Segmental Snapshot
• 2.3. Competitive Insights Snapshot

Chapter 3. Market Variables, Trends, and Scope

• 3.1. Market Lineage
  • 3.1.1. Parent Market Analysis
  • 3.1.2. Ancillary Market Analysis
• 3.2. Home Healthcare Market - Market Dynamics
  • 3.2.1. Market Driver Analysis
  • 3.2.2. Market Restraint Analysis
  • 3.2.3. Market Opportunity Analysis
  • 3.2.4. Market Challenges Analysis
• 3.3. Business Environmental Tools Analysis: Home Healthcare Market
  • 3.3.1. Porter's Five Forces Analysis
  • 3.3.2. PESTLE Analysis

Chapter 4. Home Healthcare Market: Component Estimates & Trend Analysis

• 4.1. Home Healthcare Market, By Component Key Takeaways
• 4.2. Home Healthcare Market: Component Movement & Market Share Analysis, 2026 & 2033
• 4.3. Services
  • 4.3.1. Home Healthcare Services Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.3.2. Skilled home healthcare
    • 4.3.2.1. Healthcare services market estimates and forecasts, 2021 - 2033 (USD Million)
    • 4.3.2.2. Nursing care
      • 4.3.2.2.1. Nursing care market estimates and forecasts, 2021 - 2033 (USD Million)
    • 4.3.2.3. Physician primary care
      • 4.3.2.3.1. Physician primary care market estimates and forecasts, 2021 - 2033 (USD Million)
    • 4.3.2.4. Physical/occupational/speech therapy
      • 4.3.2.4.1. Physical/occupational/speech therapy market estimates and forecasts, 2021 - 2033 (USD Million)
    • 4.3.2.5. Hospice & palliative
      • 4.3.2.5.1. Hospice & palliative market estimates and forecasts, 2021 - 2033 (USD Million)
    • 4.3.2.6. Nutritional support & infusion therapy
      • 4.3.2.6.1. Nutritional support market estimates and forecasts, 2021 - 2033 (USD Million)
    • 4.3.2.7. Other skilled home healthcare
      • 4.3.2.7.1. Other skilled home healthcare services market estimates and forecasts, 2021 - 2033 (USD Million)
  • 4.3.3. Unskilled Home Healthcare
    • 4.3.3.1. Unskilled home healthcare services market estimates and forecasts, 2021 - 2033 (USD Million)
• 4.4. Equipment
  • 4.4.1. Home Healthcare Equipment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.4.2. Therapeutic
    • 4.4.2.1. Therapeutic home healthcare equipment market estimates and forecasts, 2021 - 2033 (USD Million)
    • 4.4.2.2. Home respiratory therapy
      • 4.4.2.2.1. Home respiratory therapy market estimates and forecasts, 2021 - 2033 (USD Million)
    • 4.4.2.3. Home intravenous pumps
      • 4.4.2.3.1. Home IV pumps market estimates and forecasts, 2021 - 2033 (USD Million)
    • 4.4.2.4. Home dialysis equipment
      • 4.4.2.4.1. Home dialysis equipment market estimates and forecasts, 2021 - 2033 (USD Million)
    • 4.4.2.5. Insulin delivery
      • 4.4.2.5.1. Insulin delivery market estimates and forecasts, 2021 - 2033 (USD Million)
    • 4.4.2.6. Other therapeutic equipment
      • 4.4.2.6.1. Other therapeutic equipment market estimates and forecasts, 2021 - 2033 (USD Million)
  • 4.4.3. Diagnostic
    • 4.4.3.1. Diagnostic home healthcare equipment market estimates and forecasts, 2021 - 2033 (USD Million)
    • 4.4.3.2. Diabetic care unit
      • 4.4.3.2.1. Diabetic care unit market estimates and forecasts, 2021 - 2033 (USD Million)
    • 4.4.3.3. Blood pressure monitoring
      • 4.4.3.3.1. Blood pressure monitoring market estimates and forecasts, 2021 - 2033 (USD Million)
    • 4.4.3.4. Multi parameter diagnostics monitors
      • 4.4.3.4.1. Multi parameter diagnostics market estimates and forecasts, 2021 - 2033 (USD Million)
    • 4.4.3.5. Apnea and sleep monitors
      • 4.4.3.5.1. Apnea and sleep monitors market estimates and forecasts, 2021 - 2033 (USD Million)
    • 4.4.3.6. Home pregnancy and fertility kits
      • 4.4.3.6.1. Home pregnancy and fertility kits market estimates and forecasts, 2021 - 2033 (USD Million)
    • 4.4.3.7. Holter monitors
      • 4.4.3.7.1. Holter monitors market estimates and forecasts, 2021 - 2033 (USD Million)
    • 4.4.3.8. Heart rate meters
      • 4.4.3.8.1. Heart rate meter market estimates and forecasts, 2021 - 2033 (USD Million)
    • 4.4.3.9. Other diagnostic equipment
      • 4.4.3.9.1. Other diagnostic equipment market estimates and forecasts, 2021 - 2033 (USD Million)
  • 4.4.4. Mobility Assist Equipment
    • 4.4.4.1. Mobility assist equipment market estimates and forecasts, 2021 - 2033(USD Million)
    • 4.4.4.2. Wheelchair
      • 4.4.4.2.1. Wheelchair market estimates and forecasts, 2021 - 2033 (USD Million)
    • 4.4.4.3. Home medical furniture
      • 4.4.4.3.1. Home medical furniture market estimates and forecasts, 2021 - 2033 (USD Million)
    • 4.4.4.4. Walking assist devices
      • 4.4.4.4.1. Walking assist devices market estimates and forecasts, 2021 - 2033 (USD Million)

Chapter 5. Home Healthcare Market: Indication Estimates & Trend Analysis

• 5.1. Home Healthcare Market, By Indication: Key Takeaways
• 5.2. Home Healthcare Market: Indication Movement & Market Share Analysis, 2026 & 2033
• 5.3. Neurological & Mental Disorders
  • 5.3.1. Neurological & Mental Disorders Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 5.4. Diabetes & Kidney Disorders
  • 5.4.1. Diabetes & Kidney Disorders Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 5.5. Cancer
  • 5.5.1. Cancer Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 5.6. Respiratory Disease & COPD
  • 5.6.1. Respiratory Disease & COPD Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 5.7. Mobility Disorders
  • 5.7.1. Mobility Disorders Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 5.8. Cardiovascular Disorder & Hypertension
  • 5.8.1. Cardiovascular Disorder & Hypertension Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 5.9. Wound Care
  • 5.9.1. Wound Care Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 5.10. Maternal Disorders
  • 5.10.1. Maternal Disorders Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 5.11. Other Indications
  • 5.11.1. Other Indications Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 6. Home Healthcare Market: Regional Estimates & Trend Analysis

• 6.1. Regional Outlook
• 6.2. Home Healthcare Market by Region: Key Marketplace Takeaway
• 6.3. North America
  • 6.3.1. North America Home Healthcare Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.3.2. U.S.
    • 6.3.2.1. U.S. estimated disease burden by indication, 2021 -2033
    • 6.3.2.2. Regulatory framework & reimbursement structure
    • 6.3.2.3. Competitive scenario
    • 6.3.2.4. U.S. home healthcare market estimates and forecasts, 2021 - 2033 (USD Million)
  • 6.3.3. Canada
    • 6.3.3.1. Canada estimated disease burden by indication, 2021 -2033
    • 6.3.3.2. Regulatory framework & reimbursement structure
    • 6.3.3.3. Competitive scenario
    • 6.3.3.4. Canada home healthcare market estimates and forecasts, 2021 - 2033 (USD Million)
• 6.4. Europe
  • 6.4.1. Europe Home Healthcare Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.4.2. UK
    • 6.4.2.1. UK estimated disease burden by indication, 2021 -2033
    • 6.4.2.2. Regulatory framework & reimbursement structure
    • 6.4.2.3. Competitive scenario
    • 6.4.2.4. UK home healthcare market estimates and forecasts, 2021 - 2033 (USD Million)
  • 6.4.3. Germany
    • 6.4.3.1. Germany estimated disease burden by indication, 2021 -2033
    • 6.4.3.2. Regulatory framework & reimbursement structure
    • 6.4.3.3. Competitive scenario
    • 6.4.3.4. Germany home healthcare market estimates and forecasts, 2021 - 2033 (USD Million)
  • 6.4.4. France
    • 6.4.4.1. France estimated disease burden by indication, 2021 -2033
    • 6.4.4.2. Regulatory framework & reimbursement structure
    • 6.4.4.3. Competitive scenario
    • 6.4.4.4. France home healthcare market estimates and forecasts, 2021 - 2033 (USD Million)
  • 6.4.5. Italy
    • 6.4.5.1. Italy estimated disease burden by indication, 2021 -2033
    • 6.4.5.2. Regulatory framework & reimbursement structure
    • 6.4.5.3. Competitive scenario
    • 6.4.5.4. Italy Home healthcare market estimates and forecasts, 2021 - 2033 (USD Million)
  • 6.4.6. Spain
    • 6.4.6.1. Spain estimated disease burden by indication, 2021 -2033
    • 6.4.6.2. Regulatory framework & reimbursement structure
    • 6.4.6.3. Competitive scenario
    • 6.4.6.4. Spain home healthcare market estimates and forecasts, 2021 - 2033 (USD Million)
  • 6.4.7. Netherlands
    • 6.4.7.1. Netherlands estimated disease burden by indication, 2021 -2033
    • 6.4.7.2. Regulatory framework & reimbursement structure
    • 6.4.7.3. Competitive scenario
    • 6.4.7.4. Netherlands home healthcare market estimates and forecasts, 2021 - 2033 (USD Million)
  • 6.4.8. Sweden
    • 6.4.8.1. Sweden estimated disease burden by indication, 2021 -2033
    • 6.4.8.2. Regulatory framework & reimbursement structure
    • 6.4.8.3. Competitive scenario
    • 6.4.8.4. Sweden home healthcare market estimates and forecasts, 2021 - 2033 (USD Million)
  • 6.4.9. Ireland
    • 6.4.9.1. Ireland estimated disease burden by indication, 2021 -2033
    • 6.4.9.2. Regulatory framework & reimbursement structure
    • 6.4.9.3. Competitive scenario
    • 6.4.9.4. Ireland home healthcare market estimates and forecasts, 2021 - 2033 (USD Million)
  • 6.4.10. Russia
    • 6.4.10.1. Russia estimated disease burden by indication, 2021 -2033
    • 6.4.10.2. Regulatory framework & reimbursement structure
    • 6.4.10.3. Competitive scenario
    • 6.4.10.4. Russia home healthcare market estimates and forecasts, 2021 - 2033 (USD Million)
  • 6.4.11. Switzerland
    • 6.4.11.1. Switzerland estimated disease burden by indication, 2021 -2033
    • 6.4.11.2. Regulatory framework & reimbursement structure
    • 6.4.11.3. Competitive scenario
    • 6.4.11.4. Switzerland home healthcare market estimates and forecasts, 2021 - 2033 (USD Million)
  • 6.4.12. Denmark
    • 6.4.12.1. Denmark estimated disease burden by indication, 2021 -2033
    • 6.4.12.2. Regulatory framework & reimbursement structure
    • 6.4.12.3. Competitive scenario
    • 6.4.12.4. Denmark home healthcare market estimates and forecasts, 2021 - 2033 (USD Million)
• 6.5. Asia Pacific
  • 6.5.1. Asia Pacific Home Healthcare Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.5.2. Japan
    • 6.5.2.1. Japan estimated disease burden by indication, 2021 -2033
    • 6.5.2.2. Regulatory framework & reimbursement structure
    • 6.5.2.3. Competitive scenario
    • 6.5.2.4. Japan home healthcare market estimates and forecasts, 2021 - 2033 (USD Million)
  • 6.5.3. China
    • 6.5.3.1. China estimated disease burden by indication, 2021 -2033
    • 6.5.3.2. Regulatory framework & reimbursement structure
    • 6.5.3.3. Competitive scenario
    • 6.5.3.4. China home healthcare market estimates and forecasts, 2021 - 2033 (USD Million)
  • 6.5.4. India
    • 6.5.4.1. India estimated disease burden by indication, 2021 -2033
    • 6.5.4.2. Regulatory framework & reimbursement structure
    • 6.5.4.3. Competitive scenario
    • 6.5.4.4. India home healthcare market estimates and forecasts, 2021 - 2033 (USD Million)
  • 6.5.5. Australia
    • 6.5.5.1. Australia estimated disease burden by indication, 2021 -2033
    • 6.5.5.2. Regulatory framework & reimbursement structure
    • 6.5.5.3. Competitive scenario
    • 6.5.5.4. Australia home healthcare market estimates and forecasts, 2021 - 2033 (USD Million)
  • 6.5.6. South Korea
    • 6.5.6.1. South Korea estimated disease burden by indication, 2021 -2033
    • 6.5.6.2. Regulatory framework & reimbursement structure
    • 6.5.6.3. Competitive scenario
    • 6.5.6.4. South Korea home healthcare market estimates and forecasts, 2021 - 2033 (USD Million)
  • 6.5.7. Singapore
    • 6.5.7.1. Singapore estimated disease burden by indication, 2021 -2033
    • 6.5.7.2. Regulatory framework & reimbursement structure
    • 6.5.7.3. Competitive scenario
    • 6.5.7.4. Singapore home healthcare market estimates and forecasts, 2021 - 2033 (USD Million)
  • 6.5.8. Thailand
    • 6.5.8.1. Thailand estimated disease burden by indication, 2021 -2033
    • 6.5.8.2. Regulatory framework & reimbursement structure
    • 6.5.8.3. Competitive scenario
    • 6.5.8.4. Thailand home healthcare market estimates and forecasts, 2021 - 2033 (USD Million)
  • 6.5.9. Philippines
    • 6.5.9.1. Philippines estimated disease burden by indication, 2021 -2033
    • 6.5.9.2. Regulatory framework & reimbursement structure
    • 6.5.9.3. Competitive scenario
    • 6.5.9.4. Philippines home healthcare market estimates and forecasts, 2021 - 2033 (USD Million)
  • 6.5.10. Malaysia
    • 6.5.10.1. Malaysia estimated disease burden by indication, 2021 -2033
    • 6.5.10.2. Regulatory framework & reimbursement structure
    • 6.5.10.3. Competitive scenario
    • 6.5.10.4. Malaysia home healthcare market estimates and forecasts, 2021 - 2033 (USD Million)
  • 6.5.11. New Zealand
    • 6.5.11.1. New Zealand estimated disease burden by indication, 2021 -2033
    • 6.5.11.2. Regulatory framework & reimbursement structure
    • 6.5.11.3. Competitive scenario
    • 6.5.11.4. New Zealand home healthcare market estimates and forecasts, 2021 - 2033 (USD Million)
• 6.6. Latin America
  • 6.6.1. Latin America Home Healthcare Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.6.2. Brazil
    • 6.6.2.1. Brazil estimated disease burden by indication, 2021 -2033
    • 6.6.2.2. Regulatory framework & reimbursement structure
    • 6.6.2.3. Competitive scenario
    • 6.6.2.4. Brazil home healthcare market estimates and forecasts, 2021 - 2033 (USD Million)
  • 6.6.3. Argentina
    • 6.6.3.1. Argentina estimated disease burden by indication, 2021 -2033
    • 6.6.3.2. Regulatory framework & reimbursement structure
    • 6.6.3.3. Competitive scenario
    • 6.6.3.4. Argentina home healthcare market estimates and forecasts, 2021 - 2033 (USD Million)
  • 6.6.4. Mexico
    • 6.6.4.1. Mexico estimated disease burden by indication, 2021 -2033
    • 6.6.4.2. Regulatory framework & reimbursement structure
    • 6.6.4.3. Competitive scenario
    • 6.6.4.4. Mexico home healthcare market estimates and forecasts, 2021 - 2033 (USD Million)
• 6.7. Middle East & Africa
  • 6.7.1. Middle East & Africa SWOT Analysis
  • 6.7.2. Middle East & Africa Home Healthcare Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.7.3. South Africa
    • 6.7.3.1. South Africa estimated disease burden by indication, 2021 -2033
    • 6.7.3.2. Regulatory framework & reimbursement structure
    • 6.7.3.3. Competitive scenario
    • 6.7.3.4. South Africa home healthcare market estimates and forecasts, 2021 - 2033 (USD Million)
  • 6.7.4. Saudi Arabia
    • 6.7.4.1. Saudi Arabia estimated disease burden by indication, 2021 -2033
    • 6.7.4.2. Regulatory framework & reimbursement structure
    • 6.7.4.3. Competitive scenario
    • 6.7.4.4. Saudi Arabia home healthcare market estimates and forecasts, 2021 - 2033 (USD Million)
  • 6.7.5. UAE
    • 6.7.5.1. UAE estimated disease burden by indication, 2021 -2033
    • 6.7.5.2. Regulatory framework & reimbursement structure
    • 6.7.5.3. Competitive scenario
    • 6.7.5.4. UAE home healthcare market estimates and forecasts, 2021 - 2033 (USD Million)
  • 6.7.6. Egypt
    • 6.7.6.1. Egypt estimated disease burden by indication, 2021 -2033
    • 6.7.6.2. Regulatory framework & reimbursement structure
    • 6.7.6.3. Competitive scenario
    • 6.7.6.4. Egypt home healthcare market estimates and forecasts, 2021 - 2033 (USD Million)
  • 6.7.7. Oman
    • 6.7.7.1. Oman estimated disease burden by indication, 2021 -2033
    • 6.7.7.2. Regulatory framework & reimbursement structure
    • 6.7.7.3. Competitive scenario
    • 6.7.7.4. Oman home healthcare market estimates and forecasts, 2021 - 2033 (USD Million)